|Bid||116.79 x 700|
|Day's Range||117.39 - 118.00|
|52 Week Range||95.77 - 123.15|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.35%|
The politics around health care today could make anyone ill, but times are even more confounding for investors. Health-care stocks tanked in the lead-up to the U.S. presidential election, before reversing course and rising to become the third-best-performing sector this year, behind technology and consumer-discretionary stocks. Health-care stocks have gained 9% this year, compared to the Standard & Poor’s 500 index’s 7%.
Investors typically don’t like uncertainty, and those buying shares of biotech exchange traded funds especially don't.